Search clinical trials for: transitional cell carcinoma
Total 63949 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRenal Pelvis and Ureter Urothelial CarcinomaUnited States
-
Sumitomo Pharma America, Inc.TerminatedFallopian Tube Cancer | Primary Peritoneal Cancer | Urothelial Carcinoma | Renal Cell Carcinoma (RCC) | Platinum-resistant Ovarian Cancer (PROC) | Serous Epithelial Ovarian CancerUnited States, Canada
-
TJ Biopharma Co., Ltd.WithdrawnFirst-line Non-small-cell Lung Cancer | First-line Urothelial Carcinoma | Second-line Urothelial Carcinoma | Second-line MelanomaChina
-
Carisma Therapeutics IncActive, not recruitingAdenocarcinoma | Stomach Neoplasms | Cancer | Breast Cancer | Head and Neck Cancer | Carcinoma, Hepatocellular | Colorectal Cancer | Pancreatic Cancer | Ovarian Neoplasms | Carcinoma, Ovarian Epithelial | Carcinoma, Transitional Cell | Breast Neoplasm | Prostate Cancer | Bile Duct Cancer | Bladder Cancer | Endometrial Cancer and other conditionsUnited States
-
Weill Medical College of Cornell UniversityNeoTX Therapeutics Ltd.WithdrawnUrothelial CarcinomaUnited States
-
Taiho Oncology, Inc.Merck Sharp & Dohme LLCActive, not recruitingAdvanced and Metastatic Urothelial CancerSpain, United States, France
-
Ontario Clinical Oncology Group (OCOG)Cancer Care OntarioActive, not recruitingMuscle-invasive Bladder CancerCanada
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Renal Cell Carcinoma | Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Sarcomatoid Renal Cell Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage III Renal Pelvis Cancer AJCC v8 | Stage III Ureter Cancer AJCC v8 | Stage... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHydronephrosis | Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage III Renal Pelvis Cancer AJCC v7 | Stage III Ureter Cancer AJCC v7 | Stage III Urethral Cancer AJCC v7 | Stage IV Renal Pelvis Cancer AJCC v7 | Stage IV... and other conditionsUnited States
-
G1 Therapeutics, Inc.TerminatedBladder Cancer | Urothelial Carcinoma | Chemotherapy-induced Neutropenia | Myelosuppression Adult | Metastatic Bladder CancerHungary, Spain, United States, France, Georgia
-
Spanish Oncology Genito-Urinary GroupRoche Pharma AGCompletedLocally Advanced or Metastatic Urothelial CarcinomaSpain
-
University of UtahExelixisActive, not recruitingBladder Cancer | Metastatic Urothelial CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Bladder Carcinoma | Metastatic Urothelial Carcinoma | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Locally Advanced Bladder Urothelial Carcinoma | Metastatic Transitional Cell CarcinomaUnited States
-
Ikena OncologyBristol-Myers SquibbCompletedNeoplasms | Neoplasm Metastasis | Solid Tumor | Metastatic Cancer | Bladder Cancer | Advanced Solid Tumor | Advanced Cancer | Urothelial Carcinoma Bladder | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Solid Tumor, Adult | Bladder Disease | Solid Carcinoma | Neoplasm Malignant | Neoplasm, Bladder | Locally Advanced... and other conditionsUnited States
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedUpper Tract Urothelial Carcinomas | Urothelial Bladder CancerUnited States, France, Canada, Spain, Italy, Belgium, Germany, Netherlands, United Kingdom, Bulgaria, Greece
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube... and other conditionsUnited States
-
Kaohsiung Medical UniversityCompletedCarcinoma, Transitional Cell (RENI)
-
HiberCell, Inc.CovanceTerminatedA Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)Clear Cell Renal Cell Carcinoma | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Colo-rectal Cancer | Transitional Cell Carcinoma of the Bladder | Other Solid TumorsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Urothelial Carcinoma | Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant | Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant | Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation | Infiltrating Bladder Urothelial Carcinoma With Squamous... and other conditionsUnited States
-
Association Pour La Recherche des Thérapeutiques...Active, not recruitingInfiltrating Bladder Urothelial CarcinomaFrance
-
National Cancer Institute (NCI)WithdrawnUrothelial Carcinoma | Renal Pelvis and Ureter Urothelial Carcinoma | Bladder Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage IVA Bladder Cancer AJCC v8 | Bladder Urothelial Carcinoma | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8Canada
-
Spanish Oncology Genito-Urinary GroupAdknoma Health ResearchCompleted
-
University of FloridaCompletedUrothelial CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Active, not recruitingBladder Cancer | Urothelial Carcinoma | Metastatic Bladder CancerUnited States
-
The Netherlands Cancer InstituteAstraZenecaActive, not recruitingUrothelial CarcinomaNetherlands
-
AstraZenecaCompletedUrothelial CarcinomaUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Urothelial Carcinoma | Urothelial NeoplasmsAustralia, United States, Canada, Chile, France, Israel, Italy, Korea, Republic of, Netherlands, Spain, Taiwan, United Kingdom
-
CHU de Quebec-Universite LavalCancer Research SocietyWithdrawnMetastatic Urothelial CarcinomaCanada
-
University of OklahomaEMD Serono; Aravive, Inc.Active, not recruitingUrothelial CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Gilead SciencesActive, not recruitingMetastatic Urothelial CarcinomaUnited States
-
Incyte CorporationTerminatedUrothelial CarcinomaUnited States, France, Italy
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Urothelial Carcinoma | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Locally Advanced Urothelial Carcinoma | Recurrent Urothelial Carcinoma | Unresectable Urothelial Carcinoma | Advanced Urothelial CarcinomaUnited States
-
Chang Gung Memorial HospitalActive, not recruitingUrothelial CarcinomaTaiwan
-
Guarionex J. DecastroSanofiActive, not recruitingUrothelial Carcinoma of the Urinary BladderUnited States
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingUrothelial CarcinomaHungary, United States, Argentina, Australia, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
Pacific Edge LimitedActive, not recruitingUrothelial Carcinoma | HematuriaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingBladder Cancer | Non-Muscle-Invasive Urothelial CarcinomaUnited States
-
PfizerMerck KGaA, Darmstadt, GermanyActive, not recruiting
-
Zealand University HospitalSuspended
-
Dana-Farber Cancer InstituteBlue Earth DiagnosticsActive, not recruitingBladder Cancer | Urothelial CarcinomaUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Seromucinous Carcinoma | Recurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Fallopian Tube Mucinous Adenocarcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent... and other conditionsUnited States, Puerto Rico
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Completed
-
RenJi HospitalCompletedNeoadjuvant Immunotherapy of Cisplatin-ineligible High Risk Upper Urinary Tract Urothelial CarcinomaChina
-
Case Comprehensive Cancer CenterCompletedUrothelial CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterMayo Clinic; Hartford HospitalActive, not recruitingUrothelial CarcinomaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingBladder CancerUnited States, Canada
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Bladder Urothelial Carcinoma | Bladder Urothelial Carcinoma In Situ | Stage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Superficial Bladder Urothelial CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of Chicago; Genentech, Inc.; Ohio State University; TargosActive, not recruitingUrothelial Carcinoma | Locally Advanced | UnresectableUnited States
-
Apexigen America, Inc.CompletedMelanoma | Cancer | Head and Neck Cancer | NSCLC | Urothelial Carcinoma | MSI-HUnited States
-
RemeGen Co., Ltd.CompletedUrothelial CarcinomaChina